Testicular cancer: The usage of central review for pathology diagnosis of orchiectomy specimens

被引:14
作者
Harari, Saul E. [1 ]
Sassoon, Daniel J. [2 ]
Priemer, David S. [1 ]
Jacob, Joseph M. [4 ]
Eble, John N. [1 ]
Calio, Anna [1 ]
Grignon, David J. [1 ]
Idrees, Mohammed [1 ]
Albany, Costantine [3 ]
Masterson, Timothy A. [4 ]
Hanna, Nasser H. [3 ]
Foster, Richard S. [4 ]
Ulbright, Thomas M. [1 ]
Einhorn, Lawrence H. [3 ]
Cheng, Liang [1 ,4 ]
机构
[1] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA
[2] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA
[3] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA
[4] Indiana Univ Sch Med, Dept Urol, Indianapolis, IN 46202 USA
关键词
Testis; Germ cell tumor; Orchiectomy; Central pathology review; Pathologic staging; Vascular invasion; Differential diagnosis; SOMATIC-TYPE MALIGNANCY; STAGE-I NONSEMINOMA; GERM-CELL TUMORS; CLINICAL STAGE; CONTINUED VALUE; TESTIS; PREDICTION; MANAGEMENT; TERATOMA; CARCINOMA;
D O I
10.1016/j.urolonc.2017.05.018
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Radical orchiectomy specimens present a unique set of challenges for pathology assessment owing to their rarity and complexity. This study compares second opinion pathology reports generated at a single, large academic institution to primary reports from outside hospitals. Methods: A database search was conducted for orchiectomy cases that were sent to our institution for management of testicular cancer from 2014 to 2015. Cases sent for consultation without a finalized diagnosis from the outside hospitals were excluded. A total of 221 consecutive cases were evaluated for comparison of final diagnoses between the outside institution and central pathology review. Results: This study revealed significant discrepancy involving multiple parameters between original and second opinion pathology reports. Of 221 cases of germ cell tumors assessed, 31% showed some discrepancy of histologic subtype. Overall, reporting of lymphovascular invasion changed in 22% of cases; of those, initially called positive 23% were changed to negative and of those initially called negative 12% were changed to positive. Although the overall discrepancy for spermatic cord invasion was 9%, an initial positive diagnosis was negated 35% of the time. The pathologic stage was altered in 23% of cases, mostly secondary to differences interpreting lymphovascular and spermatic cord invasion. Conclusion: Pathologists evaluating orchiectomy specimens should be aware of the major pitfalls in classification and staging, many of which may affect patient management. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:605.e9 / 605.e16
页数:8
相关论文
共 31 条
[1]   Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: Results of the German Testicular Cancer Study Group Trial [J].
Albers, P ;
Siener, R ;
Kliesch, S ;
Weissbach, L ;
Krege, S ;
Sparwasser, C ;
Schulze, H ;
Heidenreich, A ;
de Riese, W ;
Loy, V ;
Bierhoff, E ;
Wittekind, C ;
Fimmers, R ;
Hartmann, M .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (08) :1505-1512
[2]   Guidelines on Testicular Cancer: 2015 Update [J].
Albers, Peter ;
Albrecht, Walter ;
Algaba, Ferran ;
Bokemeyer, Carsten ;
Cohn-Cedermark, Gabriella ;
Fizazi, Karim ;
Horwich, Alan ;
Laguna, Maria Pilar ;
Nicolai, Nicola ;
Oldenburg, Jan .
EUROPEAN UROLOGY, 2015, 68 (06) :1054-1068
[3]   Clinicopathologic Analysis of Choriocarcinoma as a Pure or Predominant Component of Germ Cell Tumor of the Testis [J].
Alvarado-Cabrero, Isabel ;
Hernandez-Toriz, Narciso ;
Paner, Gladell P. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2014, 38 (01) :111-118
[4]  
[Anonymous], 2016, SEER STAT FACT SHEET
[5]   Handling and reporting of orchidectomy specimens with testicular cancer: areas of consensus and variation among 25 experts and 225 European pathologists [J].
Berney, Daniel M. ;
Algaba, Ferran ;
Amin, Mahul ;
Delahunt, Brett ;
Comperat, Eva ;
Epstein, Jonathan I. ;
Humphrey, Peter ;
Idrees, Mohammed ;
Lopez-Beltran, Antonio ;
Magi-Galluzzi, Cristina ;
Mikuz, Gregor ;
Montironi, Rodolfo ;
Oliva, Esther ;
Srigley, John ;
Reuter, Victor E. ;
Trpkov, Kiril ;
Ulbright, Thomas M. ;
Varma, Murali ;
Verrill, Clare ;
Young, Robert H. ;
Zhou, Ming ;
Egevad, Lars .
HISTOPATHOLOGY, 2015, 67 (03) :313-324
[6]   Perspectives on testicular germ cell neoplasms [J].
Cheng, Liang ;
Lyu, Bingjian ;
Roth, Lawrence M. .
HUMAN PATHOLOGY, 2017, 59 :10-25
[7]   Management of clinical stage I nonseminomatous germ cell testicular cancer [J].
Choueiri, Toni K. ;
Stephenson, Andrew J. ;
Gilligan, Timothy ;
Klein, Eric A. .
UROLOGIC CLINICS OF NORTH AMERICA, 2007, 34 (02) :137-+
[8]   Surveillance for Stage I Nonseminoma Testicular Cancer: Outcomes and Long-Term Follow-Up in a Population-Based Cohort [J].
Daugaard, Gedske ;
Gundgaard, Maria Gry ;
Mortensen, Mette Sakso ;
Agerbaek, Mads ;
Holm, Niels Vilstrup ;
Rorth, Mikael ;
von der Maase, Hans ;
Christensen, Ib Jarle ;
Lauritsen, Jakob .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (34) :3817-3823
[9]   The continued value of central histopathological review of testicular tumours [J].
Delaney, RJ ;
Sayers, CD ;
Walker, MA ;
Mead, GM ;
Theaker, JM .
HISTOPATHOLOGY, 2005, 47 (02) :166-169
[10]  
FREEDMAN LS, 1987, LANCET, V2, P294